FRI0503 Eular-Pres Points to Consider for the Use of Imaging in the Diagnosis and Management of Juvenile Idiopathic Arthritis in Clinical Practice. (9th June 2015)
- Record Type:
- Journal Article
- Title:
- FRI0503 Eular-Pres Points to Consider for the Use of Imaging in the Diagnosis and Management of Juvenile Idiopathic Arthritis in Clinical Practice. (9th June 2015)
- Main Title:
- FRI0503 Eular-Pres Points to Consider for the Use of Imaging in the Diagnosis and Management of Juvenile Idiopathic Arthritis in Clinical Practice
- Authors:
- Colebatch-Bourn, A.N.
Edwards, C.J.
Collado, P.
D'Agostino, M.A.
Hemke, R.
Jousse-Joulin, S.
Maas, M.
Martini, A.
Naredo, E.
Østergaard, M.
Rooney, M.
Tzaribachev, N.
van Rossum, M.
Vojinovic, J.
Conaghan, P.G.
Malattia, C. - Abstract:
- Abstract : Objectives: To develop evidence based points to consider on the use of imaging in the diagnosis and management of juvenile idiopathic arthritis (JIA) in clinical practice. Methods: The task force comprised an expert group of adult and paediatric rheumatologists, radiologists, and methodologists from 9 countries. Eleven key questions on the role of imaging in JIA were generated using a process of discussion and consensus. Imaging modalities included were conventional radiography (CR), ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT), scintigraphy and positron emission tomography (PET). Research evidence was searched systematically for each question using MEDLINE, EMBASE and Cochrane CENTRAL. The experts used the evidence obtained from the relevant studies to develop a set of points to consider. The task force assessed their level of agreement with each point to consider using a numerical rating scale. Quality assessment of the included studies was performed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool. Results: A total of 13, 277 references were identified from the search process, from which 204 studies were included in the systematic review. Nine points to consider were produced encompassing the role of imaging in making a diagnosis of JIA, detecting and monitoring inflammation and damage, predicting outcome and response to treatment, use of guided therapies, progression and remission (table ). The level ofAbstract : Objectives: To develop evidence based points to consider on the use of imaging in the diagnosis and management of juvenile idiopathic arthritis (JIA) in clinical practice. Methods: The task force comprised an expert group of adult and paediatric rheumatologists, radiologists, and methodologists from 9 countries. Eleven key questions on the role of imaging in JIA were generated using a process of discussion and consensus. Imaging modalities included were conventional radiography (CR), ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT), scintigraphy and positron emission tomography (PET). Research evidence was searched systematically for each question using MEDLINE, EMBASE and Cochrane CENTRAL. The experts used the evidence obtained from the relevant studies to develop a set of points to consider. The task force assessed their level of agreement with each point to consider using a numerical rating scale. Quality assessment of the included studies was performed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool. Results: A total of 13, 277 references were identified from the search process, from which 204 studies were included in the systematic review. Nine points to consider were produced encompassing the role of imaging in making a diagnosis of JIA, detecting and monitoring inflammation and damage, predicting outcome and response to treatment, use of guided therapies, progression and remission (table ). The level of evidence, grade of recommendation and level of agreement for each proposition are given in the table, and vary according to both the research evidence and expert opinion. Conclusions: Nine key points to consider for the role of imaging in the management of JIA were developed using research based evidence and expert opinion. Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 74(2015)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 74(2015)Supplement 2
- Issue Display:
- Volume 74, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 74
- Issue:
- 2
- Issue Sort Value:
- 2015-0074-0002-0000
- Page Start:
- 611
- Page End:
- 611
- Publication Date:
- 2015-06-09
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2015-eular.1663 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17936.xml